J M Feldman, B Chapman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AnimalsCatechol O-Methyltransferase InhibitorsCatecholamines/antagonists & inhibitorsCatecholamines/metabolismCells, CulturedCocaine/metabolismCricetinaeCulture MediaDopamine/administration & dosageDopamine/metabolismDrug SynergismImipramine/metabolismInsulin/metabolismInsulin SecretionIslets of Langerhans/enzymologyIslets of Langerhans/metabolismLevodopa/administration & dosageMonoamine Oxidase/metabolismMonoamine Oxidase Inhibitors/administration & dosageNortriptyline/metabolismPargyline/administration & dosageRabbitsRatsSpecies SpecificityStimulation, ChemicalTranylcypromine/administration & dosage
Substances： See more » Catechol O-Methyltransferase InhibitorsCatecholaminesCulture MediaInsulinMonoamine Oxidase InhibitorsTranylcypromineLevodopaPargylineNortriptylineMonoamine OxidaseCocaineImipramineDopamine
Year: 1974 PMID： 4606797 DOI： 10.2337/diab.23.9.754
Source DB: PubMed Journal: Diabetes ISSN： 0012-1797 Impact factor: 9.461